Direct determination of cadmium in urine by tungsten-coil inductively coupled plasma atomic emission spectrometry using palladium as a permanent modifier.
Cadmium is determined in urine samples collected from patients with age-related diseases. The urine is simply diluted 1:1 with water and placed on a tungsten coil electrothermal vaporizer treated with 200mug of a permanent Pd modifier. A straightforward vaporization program is used to deliver the Cd vapor to an inductively coupled plasma atomic emission spectrometer. A high resolution spectrometer and a charge coupled device detector provide spectra across a 4.8nm window encompassing two separate Cd emission lines: 226.5 and 228.8nm. The limit of detection is 0.2mug/L at each wavelength, and the linear dynamic range spans three orders of magnitude. The accuracy as measured with a urine standard reference material is 94%. The Pd modifier continues to be effective even after 150 vaporization cycles. Direct analysis of urine with the Pd modifier using simple aqueous calibration solutions provides results that are comparable to those observed after a much more complex method: chelation, extraction, and internal standardization without the modifier. The mean concentrations found by the two techniques differ by only 9%. The permanent Pd modifier allows direct analysis of limited sample volumes with decreased risks of contamination.